Zum Hauptinhalt springen

Verschiedene

26. April 2017 | Verschiedene

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial Anderson, Ian MBlakeley, Claire et al…

26. April 2017 | Verschiedene

Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight

Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight Singh, Ilina et al. The Lancet Psychiatry , Volume 4 , Issue 5 , 419 - 426 http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(17)30102-5/f…

25. April 2017 | Verschiedene

The Effects of Psychoactive Prescription Drugs on Driving.

The Effects of Psychoactive Prescription Drugs on Driving. Beirness, D. (2017). Ottawa, Ont.: Canadian Centre on Substance Abuse. http://ccsa.ca/Resource%20Library/CCSA-Psychoactive-Prescription-Drugs-and-Driving-Report-2017-en.pdf

21. April 2017 | Verschiedene

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Michael M. Schartner, Robin L. Carhart-Harris, Adam B. Barrett, Anil K. Seth & Suresh D. Muthukumaraswamy Nature, Scientific Reports 7, Article&n…

17. April 2017 | Verschiedene

Personal View: Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight

Personal View: Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight Prof Ilina Singh, Prof Celia Morgan, PhD, Prof Valerie Curran, PhD, Prof David Nutt, MD, Anne Schlag, PhD, Rupert McShane, PhD The Lancet…

17. April 2017 | Verschiedene

Comment: The practicalities and ethics of ketamine for depression

Comment: The practicalities and ethics of ketamine for depression Christopher James Ryan, Colleen Loo The Lancet Psychiatry, Published: 05 April 2017 doi.org/10.1016/S2215-0366(17)30155-4 http://www.thelancet.com/journals/lanpsy/article/PIIS2215…

13. April 2017 | Verschiedene

USA. Addicts Who Can't Get Opioids Are Overdosing on a Diarrhea Drug (Loperamid)

“We’ve had patients tell us they take 400 to 500 tablets day … They put it in a blender and make a smoothie and drink it over one or two hours.” (The Atlantic, 07.04.2017) https://www.theatlantic.com/health/archive/2017/04/…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten